(Post-)Graduate Support at its Best!

10 March 2026 | 16:30 | online

Dr. Jennifer Christina Hartel completed her PhD in immunology at the Institute of Clinical Pharmacology in Frankfurt am Main, working in the lab of Prof. Grösch. She then continued her research on ceramide synthases as a postdoc in the same lab for approximately one year before leaving academia. Since January 2025, she has worked at The Frankfurt Institute for Clinical Cancer Research (IKF) in the project management of clinical trials. She will discuss her transition from academia to the field of clinical trials.

Please register here

17.9.2025 | 17:00 | online

Dr. Marina Dajka studied chemistry at Goethe University. For her PhD, she studied the structure and function of a membrane protein using biophysical spectroscopy and defended her thesis in biochemistry. During this time, she was active in the JCF Frankfurt and the student council, serving as a Ph.D. spokesperson.

After receiving additional training in project and quality management, as well as the fundamentals of the pharmaceutical industry, she joined Merck in April 2025 as a quality control senior expert in method development and validation (deputy head of laboratory). She will give insights into content and requirements of her current position and share her view on the difference between academia and the pharmaceutical industry.

Please use the following link to take part in the event:

https://uni-frankfurt.zoom-x.de/j/66459386550?pwd=9Tz3MatamMV29IYGRAxcoiej6WbebJ.1
Meeting-ID: 664 5938 6550
Kenncode: 311553

15.9.2025 | 16:30 | online

Join Dr. Clara Brieke, Director at Simon-Kucher, as she shares her personal journey from academic research to strategic consulting in the life sciences industry.

After completing a PhD in Chemistry at Goethe University’s Heckel Lab, followed by a Postdoc and several years of research on own research topics at the Max Planck Institute for Medical Research in Heidelberg, she decided to shift gears and pursued a part-time MBA to explore new career paths beyond academia.

Today, Clara leads projects in the Life Sciences Division at Simon-Kucher, focusing on pricing strategies for innovative therapies and early market potential assessments for both major pharmaceutical firms and cutting-edge biotech start-ups. As a specialist in Germany’s AMNOG process, she has guided companies in crafting and executing price negotiation strategies that optimize access and value.

In this session, Clara will reflect on the parallels and differences between science and consulting, why it is interesting to consider a career in consulting, and why it is a fulfilling job. You’ll also gain insights into the challenges that innovative therapies face after clinical development and regulatory approval—factors that increasingly shape decision-making in pharmaceutical development. Learn why “thinking from the end” is critical in bringing innovations to patients.

You can participate via the following link:

https://uni-frankfurt.zoom-x.de/j/62436863144?pwd=FzLHPbAOV29hm4nbFAKA0aFm1nJ00w.1
Meeting-ID: 624 3686 3144
Kenncode: 975865

3. April 2025 | 16:30 Uhr | online

Dr. Tabea Osthues has gained extensive experience over the past several years in quality control, patient safety, and medical affairs within leading biotech and pharmaceutical companies. She holds a Master’s degree in Molecular Medicine and a PhD in Pharmacy from Goethe University Frankfurt, with deep expertise in immunology, neurology, and pharmaceutical research.
She began her career as a scientist in the quality control department at BioNTech IMFS GmbH, where she managed high-level deviations and oversaw GMP-compliant testing and approvals for the COVID-19 vaccine. She then transitioned to Novartis Pharma GmbH as a Patient-Oriented Programs (POP) Governance Specialist, supporting the planning, execution, and monitoring of patient engagement programs while also overseeing vendor qualification for global process implementation.
In her current role as a Scientific Education Manager, she supports the therapeutic area of dyslipidemia by coordinating the production of high-quality scientific video, podcast, and print projects, which are certified by the Medical Association as accredited training materials for physicians. Additionally, she reviews content for live and on-demand courses and provides strategic guidance on compliance with German regulations. She also oversees the independent “Ärztlicher Beirat” committee at Novartis, where physicians from various indications provide expert guidance on educational training initiatives.
Join us for this opportunity to gain valuable insights from her experience across diverse roles in the pharmaceutical industry.

Link for registration